Management of cardiovascular complications of bruton tyrosine kinase inhibitors.

Tang, Chloe Pek Sang; Lip, Gregory Y H; McCormack, Terry; Lyon, Alexander R; Hillmen, Peter; Iyengar, Sunil; Martinez-Calle, Nicolas; Parry-Jones, Nilima; Patten, Piers E M; Schuh, Anna; Walewska, Renata

Tang, Chloe Pek Sang; Lip, Gregory Y H; McCormack, Terry; Lyon, Alexander R; Hillmen, Peter; Iyengar, Sunil; Martinez-Calle, Nicolas; Parry-Jones, Nilima; Patten, Piers E M; Schuh, Anna; Walewska, Renata.

Afiliación

Tang CPS; Oxford University Hospitals NHS Trust, Oxford, UK.
Lip GYH; Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK.
McCormack T; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Lyon AR; Hull York Medical School, Hull, UK.
Hillmen P; Royal Brompton NHS Trust, London, UK.
Iyengar S; Leeds Teaching Hospital NHS Trust, Leeds, UK.
Martinez-Calle N; Royal Marsden Hospital NHS Trust, Sutton, UK.
Parry-Jones N; Nottingham University Hospitals NHS Trust, Nottingham, UK.
Patten PEM; Aneurin Bevan University Health Board, Abergavenny, UK.
Schuh A; Comprehensive Cancer Centre, Kings College London, London, UK.
Walewska R; Oxford University Hospitals NHS Trust, Oxford, UK.

Br J Haematol ; 196(1): 70-78, 2022 01.

Article en En | MEDLINE | ID: mdl-34498258

Asunto(s)

Agammaglobulinemia Tirosina Quinasa/antagonistas & inhibidores; Enfermedades Cardiovasculares/diagnóstico; Enfermedades Cardiovasculares/etiología; Sistema Cardiovascular/efectos de los fármacos; Inhibidores de Proteínas Quinasas/efectos adversos; Animales; Enfermedades Cardiovasculares/terapia; Toma de Decisiones Clínicas; Diagnóstico Diferencial; Manejo de la Enfermedad; Susceptibilidad a Enfermedades; Humanos; Inhibidores de Proteínas Quinasas/administración & dosificación; Inhibidores de Proteínas Quinasas/uso terapéutico; Factores de Riesgo

Palabras clave

atrial fibrillation; bruton tyrosine kinase inhibitor; cardiovascular complication; hypertension; ibrutinib; sudden cardiac death

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Sistema Cardiovascular / Inhibidores de Proteínas Quinasas / Agammaglobulinemia Tirosina Quinasa Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Animals / Humans Idioma: En Revista: Br J Haematol Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google